FindTrial
Sign In

Application of single cell detection of circulating tumor cells in immunotherapy of lung cancer

Application of single cell detection of circulating tumor cells in immunotherapy of lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009993
Enrollment
Unknown
Registered
2016-11-24
Start date
2016-12-31
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Gold Standard:In situ tumor tissue
Index test:PD-L1&#32
expression&#32
of&#32
CTC&#32
and&#32
new&#32
cancer&#32
antigen

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Advanced lung cancer Patients

Exclusion criteria

Exclusion criteria: The patient is not suitable for the trial

Design outcomes

Primary

MeasureTime frame
PD-L1 expression of CTC;new cancer antigen;—

Countries

China

Contacts

Public ContactLu Shun

Shanghai Chest Hospital

shun_lu@hotmail.com+86 13601813062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026